John Clerici counsels new entrants to the government marketplace and existing government contractors in developing effective strategies to sell goods and services to the federal, state, and local governments.
He has substantial experience with all aspects of government relations, including providing targeted legislative and regulatory solutions as well as advice regarding appropriate contract vehicles and corporate structures to maximize business opportunities and limit potential liability. With his strong background in this area, John served as a legislative and legal adviser for a major defense contractor regarding the drafting and legislative strategy for a major component of the Homeland Security Act of 2002 known as the “SAFETY Act.”
John also advises clients seeking privatized military housing contracts, including monitoring and affecting public policy governing the various practices of the military departments with respect to housing privatization as well as post-award negotiation and administration of privatized contracts. In this capacity, he advised the country’s largest provider of privatized military housing to successfully develop and implement its business, legal, and government affairs strategy to capture over six billion dollars of public-private partnerships with the Department of Defense.
Notably, John has played a significant role in the creation and growth of the public health preparedness sector for nearly two decades, helping large pharmaceutical and emerging biotechnology companies access non-dilutive capital to fund the development of biotechnology for emerging disease and engineered threats. He has assisted more than three dozen companies in obtaining over four billion dollars in funding for the research, development, and procurement of public health countermeasures to the federal government, including the majority of the awards made under Project BioShield, the federal government’s initiative to prepare the United States against a bioterrorist attack. Using his strong background in this area, he testified as an expert in support of this legislation on four occasions before the United States Senate Appropriations Committee, HELP Committee, and Judiciary Committee. He was also instrumental in the passage of legislation creating the Biomedical Advanced Research and Development Authority, which builds upon and improves Project BioShield.
He was also pivotal in the drafting and passage of the Public Readiness and Emergency Preparedness Act, known as the PREP Act, landmark legislation that provides substantial liability protections for makers and distributors of pandemic, epidemic, and bioterrorism countermeasures.
Prior to joining Blank Rome, John served as a partner at leading Am Law 100 firms. He is also a founding principal at Tiber Creek Partners, assisting biotechnology companies that seek to use non-dilutive capital from the U.S. government, foreign governments, and non-governmental organizations as part of their commercialization objectives. Prior to entering private practice, John was a judge advocate in the U.S. Air Force where, among other assignments, he advised the Air Force Research Laboratory on the procurement of technology from research institutions throughout the United States, Europe, and Asia.
John has appeared as a military law analyst on the Fox News Channel and MSNBC before national audiences.